In vitro and in vivo, MTAP may act as a tumor suppressor, serving antiangiogenic, antiproliferative, and antimigratory or antiinvasive functions, and its deficiency represents a potential therapeutic target of myxofibrosarcomas. Here, MTAP is linked to myxofibrosarcoma.